Effects of visualization of successful revascularization on chest pain and quality of life

Not Applicable

• Conditions: I25; Chronic ischaemic heart disease

• Registration Number: DRKS00017524
• Lead Sponsor: niversitätsklinikum Regensburg

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2019-07-05
• Study Completion: 2021-03-31
• Results First Posted: 2021-11-15
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 145

Inclusion Criteria

symptomatic CAD (coronary artery disease)
- CCS >=2 (Canadian Cardiovascular Society)
- AP-frequency >=2/week
- German-speaking

Exclusion Criteria

- EF <35% (ejection fraction)
- severe pulmonary disease
- impaired vision
- impaired hearing
- dementia
- drugs with influence on the opiod system
- high grade valve impairment
- Hb <=7 mg/dL
- participation in other interventional clinical trial

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The Seattle Angina Questionnaire (SAQ) derived Quality of life score is assessed during the hospital stay of the angioplasty. This is repeated after 1 and 6 months in a phone interview. Primary endpoint of this study is the change in the quality of life as it is meassured in the Seattle Angina Questionnaire one and six months after stent implantation. This questionnaire is filled out by the study doctor together with the patient during the initiatl hospital stay. The follow up after 1 and 6 months is performed in a telephone interview.

Secondary Outcome Measures

Name	Time	Method
Secondary endpoints are changes in the other derived SAQ-Scores (physical limitation, angina stability, Angina frequency, treatment satisfaction, disease perception) and the dyspnea (NYHA Score) after 1 and 6 months compared to the intial assessment during the initial hospital stay.